Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
Blood (2001) 98 (3): 548–553.
Currently there are no citedby results. Try again later.
